Philip A. Kemp

1.1k total citations
25 papers, 997 citations indexed

About

Philip A. Kemp is a scholar working on Physiology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Philip A. Kemp has authored 25 papers receiving a total of 997 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Physiology, 13 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in Philip A. Kemp's work include Nitric Oxide and Endothelin Effects (16 papers), Heart Rate Variability and Autonomic Control (6 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). Philip A. Kemp is often cited by papers focused on Nitric Oxide and Endothelin Effects (16 papers), Heart Rate Variability and Autonomic Control (6 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (5 papers). Philip A. Kemp collaborates with scholars based in United Kingdom and United States. Philip A. Kemp's co-authors include Sheila M. Gardiner, Terence Bennett, Alan D. Jackson, A.M. Compton, J E March, Rosemary Sugar, S P H Alexander, E.Andrew Boyd, Michael D. Randall and David A. Kendall and has published in prestigious journals such as Diabetes, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Philip A. Kemp

25 papers receiving 971 citations

Peers

Countries citing papers authored by Philip A. Kemp

Since Specialization

Citations

This map shows the geographic impact of Philip A. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip A. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip A. Kemp more than expected).

Fields of papers citing papers by Philip A. Kemp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip A. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip A. Kemp. The network helps show where Philip A. Kemp may publish in the future.

Co-authorship network of co-authors of Philip A. Kemp

This figure shows the co-authorship network connecting the top 25 collaborators of Philip A. Kemp. A scholar is included among the top collaborators of Philip A. Kemp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip A. Kemp. Philip A. Kemp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting in vivo cardiovascular properties of β‐blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses 2011 ·The FASEB Journal ·Jillian G. Baker, Philip A. Kemp, J E March, (unknown), Stephen J. Hill, Sheila M. Gardiner	20
2	Mesenteric Vasoconstriction and Hindquarters Vasodilatation Accompany the Pressor Actions of Exendin-4 in Conscious Rats 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Sheila M. Gardiner, J E March, Philip A. Kemp, Terence Bennett	47
3	Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK‐357,903, in conscious SHR 2004 ·British Journal of Pharmacology ·Sheila M. Gardiner, J E March, Philip A. Kemp, Stephen A. Ballard, (unknown), Bernadette Hughes, Terence Bennett	6
4	Regional Hemodynamic Actions of Selective Corticotropin-Releasing Factor Type 2 Receptor Ligands in Conscious Rats 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Sheila M. Gardiner, J E March, Philip A. Kemp, Anthony P. Davenport, Katherine Wiley, Terence Bennett	22
5	Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response 2004 ·British Journal of Pharmacology ·Sheila M. Gardiner, J E March, Philip A. Kemp, Terence Bennett	30
6	Nucleotide-Mediated Mucin Secretion from Differentiated Human Bronchial Epithelial Cells 2004 ·American Journal of Respiratory Cell and Molecular Biology ·Philip A. Kemp, Rosemary Sugar, Alan D. Jackson	81
7	Inhibition of chloride secretion in human bronchial epithelial cells by cigarette smoke extract 2004 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·James L. Kreindler, Alan D. Jackson, Philip A. Kemp, Robert J. Bridges, Henry Danahay	121
8	Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S‐methyl‐L‐thiocitrulline and L‐NAME, in conscious rats 2003 ·British Journal of Pharmacology ·Ian Wakefield, J E March, Philip A. Kemp, Jean‐Pierre Valentin, Terence Bennett, Sheila M. Gardiner	31
9	An Endogenous Cannabinoid as an Endothelium-Derived Vasorelaxant 1996 ·Biochemical and Biophysical Research Communications ·Michael D. Randall, S P H Alexander, (unknown), E.Andrew Boyd, Jeffrey R. Fry, Sheila M. Gardiner, Philip A. Kemp, (unknown), David A. Kendall	225
10	Regional Haemodynamics in Brattleboro Rats During Chronic Ingestion of N^G-nitro-L-arginine Methyl Ester 1993 ·Blood Pressure ·Sheila M. Gardiner, Philip A. Kemp, T. Bennett	7
11	Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats 1993 ·British Journal of Pharmacology ·Sheila M. Gardiner, Philip A. Kemp, Terence Bennett	16
12	Involvement of capsaicin‐sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin 1992 ·British Journal of Pharmacology ·Hélène Bachelard, Sheila M. Gardiner, Philip A. Kemp, (unknown)	13
13	Mechanisms contributing to the regional haemodynamic effects of neurotensin in conscious, unrestrained Long Evans rats 1992 ·British Journal of Pharmacology ·Hélène Bachelard, Sheila M. Gardiner, Philip A. Kemp, Terence Bennett	12
14	Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats 1992 ·European Journal of Pharmacology ·Sheila M. Gardiner, Philip A. Kemp, Terence Bennett, Richard Palmer, Salvador Moncada	70
15	The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1–38] in conscious rats 1991 ·British Journal of Pharmacology ·Sheila M. Gardiner, A.M. Compton, Philip A. Kemp, Terence Bennett	35
16	Human α-calcitonin gene-related peptide (CGRP)-(8–37), but not-(28–37), inhibits carotid vasodilator effects of human α-CGRP in vivo 1991 ·European Journal of Pharmacology ·Sheila M. Gardiner, A.M. Compton, Philip A. Kemp, Terence Bennett, (unknown), (unknown), Bernadette Hughes	21
17	Effects of N^G‐nitro‐l‐arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats 1991 ·British Journal of Pharmacology ·Sheila M. Gardiner, A.M. Compton, Philip A. Kemp, Terence Bennett	34
18	Effects of N^G‐nitro‐l‐arginine methyl ester on vasodilator responses to acetylcholine, 5′‐N‐ethylcarboxamidoadenosine or salbutamol in conscious rats 1991 ·British Journal of Pharmacology ·Sheila M. Gardiner, Philip A. Kemp, Terence Bennett	93
19	Hemodynamic Effects of NG-Monomethyl-L-Arginine and NG-Nitro-L-Arginine Methyl Ester in Conscious, Unrestrained Rats 1991 ·Journal of Cardiovascular Pharmacology ·Sheila M. Gardiner, A.M. Compton, Philip A. Kemp, Terence Bennett	10
20	Synergistic internal carotid vasodilator effects of human α‐calcitonin gene‐related peptide and nimodipine in conscious rats 1990 ·British Journal of Pharmacology ·Sheila M. Gardiner, A.M. Compton, (unknown), Philip A. Kemp, Ursula M. Ney	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact